Posted Feb. 20, 2013 at 9:13 a.m.

Premium Lock Triangle startup receives 'orphan drug' designation for testosterone treatment

Published: 2013-02-20 09:13:32
Updated: 2013-02-20 09:13:32

SOV Therapeutics SOV Therapeutics

SOV Therapeutics, a drug company formed in 2009 and based in Morrisville, has received orphan drug status from the FDA for its proposed testosterone treatment targeting boys who are afflicted with constitutional delay of growth and puberty....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll